Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders-Reference-Cited by-同舟云学术

Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders

Published:2020-02 Issue: Volume:134 Page:104619
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Messer Anne,Butler David C.

Funder

National Institutes of Health

Hereditary Disease Foundation

National Parkinson's Foundation

Parkinson's Disease Foundation

Huntington's Disease Society of America

High Q Foundation

CHDI Foundation

Michael J Fox Foundation

Publisher

Elsevier BV

Subject

Neurology

Reference172 articles.

1. Crystallization and preliminary X-ray diffraction analysis of a specific VHH domain against mouse prion protein;Abskharon;Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun.,2010

2. Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a Nanobody;Abskharon;J. Am. Chem. Soc.,2014

3. Games played by rogue proteins in Prion disorders and Alzheimer’s disease;Aguzzi;Science,2003

4. Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity;Aiken;J. Biol. Chem.,2009

5. An Intrabody drug (rAAV6-INT41) reduces the binding of N-terminal Huntingtin fragment(s) to DNA to basal levels in PC12 cells and delays cognitive loss in the R6/2 animal model;Amaro;J. Neurodegener. Dis.,2016

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a synthetic library of humanized nanobodies for targeted IL-6 inhibition;Frontiers in Bioengineering and Biotechnology;2024-07-23

2. Why Is Arginine the Only Amino Acid That Inhibits Polyglutamine Monomers from Taking on Toxic Conformations?;ACS Chemical Neuroscience;2024-07-15

3. Fully Human Bifunctional Intrabodies Achieve Graded Reduction of Intracellular Tau and Rescue Survival ofMAPTMutation iPSC-derived Neurons;2024-06-01

4. Single-domain antibody-based protein degrader for synucleinopathies;Molecular Neurodegeneration;2024-05-31

5. A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein;Journal of Biological Chemistry;2024-04